Exact Mass: 460.1127
Exact Mass Matches: 460.1127
Found 53 metabolites which its exact mass value is equals to given mass value 460.1127,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Ponesimod
ParishinE
Parishin E is a natural product found in Gastrodia elata with data available. Parishin E, a parishin derivative isolated from Gastrodia elata, may have antioxidant property[1]. Parishin E, a parishin derivative isolated from Gastrodia elata, may have antioxidant property[1].
Parishin
Parishin E is a natural product found in Gastrodia elata with data available. Parishin E, a parishin derivative isolated from Gastrodia elata, may have antioxidant property[1]. Parishin E, a parishin derivative isolated from Gastrodia elata, may have antioxidant property[1].
(R)-4,4-dihydroxy-3-(4-dihydroxyphenyl)spiro{2,10-dioxatricyclo[12.2.2.13,7]nonadeca-1,(16),3,5,7(19),14,17-hexaene-12,2(5H)-furan}-11,5-dione|(R)-4,4-dihydroxy-3-(4-hydroxyphenyl)spiro{2,10-dioxatricyclo[12.2.2.13,7]nonadeca-1(17),3,5,7(19),14(18),15-hexaene-12,2(5H)-furan}-11,5-dione|retipolide E
3,3-Dimethyl-6-hydroxy-9beta-(1-methylethenyl)-11-methoxy-9a,13a-epoxy-3H,7H-4,14-dioxadibenz[a,j]anthracene-7,10,13-trione
6-Chloro-N-[(9H-fluoren-9-ylmethoxy)carbonyl]tryptoph
Levocetirizine dihydrochloride
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Levocetirizine dihydrochloride ((R)-Cetirizine dihydrochloride) is a third-generation peripheral H1-receptor antagonist. Levocetirizine dihydrochloride is an antihistaminic agent which is the R-enantiomer of Cetirizine. Levocetirizine dihydrochloride has a higher affinity for the histamine H1-receptor than (S)-Cetirizine and can effectively treat allergic rhinitis and chronic idiopathic urticaria[1].
1,3,5-tri-O-benzoyl-2-oxo-α-D-erythro-pentofuranose
Losartan potassium
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents B - Blood and blood forming organs > B03 - Antianemic preparations Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Losartan potassium (DuP-753 potassium) is an angiotensin II receptor type 1 (AT1) antagonist, competing with the binding of angiotensin II to AT1 with an IC50 of 20 nM.
Cetirizine hydrochloride
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018926 - Anti-Allergic Agents Cetirizine dihydrochloride, a second-generation antihistamine and the carboxylated metabolite of hydroxyzine, is a specific, orally active and long-acting histamine H1-receptor antagonist. Cetirizine dihydrochloride marks antiallergic properties and inhibits eosinophil chemotaxis during the allergic response[1][2][3].
Ponesimod
L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants > L04AA - Selective immunosuppressants D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents > D000081243 - Sphingosine 1 Phosphate Receptor Modulators C308 - Immunotherapeutic Agent
N-[5-[2-(3,4-dihydro-2H-quinolin-1-yl)-2-oxoethyl]sulfanyl-1,3,4-thiadiazol-2-yl]naphthalene-1-carboxamide
2-(5-{5-[Amino(iminio)methyl]-1H-benzimidazol-2-YL}-2-fluoro-6-oxido-1,1-biphenyl-3-YL)succinate
Aspartyl adenylate beta-ketophosphonate isostere
An organic phosphonate that is adenosine having a [(3S)-3-amino-4-carboxy-2-oxobutyl](hydroxy)phosphoryl group attached at position 5.
(5Z)-5-[[3-chloro-4-(2,3-dihydroxypropoxy)phenyl]methylidene]-3-(2-methylphenyl)-2-propylimino-1,3-thiazolidin-4-one
(2R)-2-[(4R,5S)-8-bromo-5-[[cyclopropylmethyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4R,5S)-8-bromo-5-[[cyclopropylmethyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4S,5R)-8-bromo-5-[[cyclopropylmethyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4S,5R)-8-bromo-5-[[cyclopropylmethyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
4-[[3-(3-methoxyphenyl)-3-oxopropylidene]amino]-N-quinoxalin-2-ylbenzenesulfonamide
Cetirizine Impurity C (dihydrochloride)
Cetirizine Impurity C dihydrochloride is an impurity of Cetirizine. Cetirizine, a second-generation antihistamine and the carboxylated metabolite of hydroxyzine, is a specific, orally active and long-acting histamine H1-receptor antagonist[1][2].
Octoclothepin (maleate salt)
Octoclothepin maleate salt, an orally active neuroleptic agent, is a dual SR-2A and D2DR inhibitor. Octoclothepin maleate salt reveals an intensive central depressant action in a series of observational and instrumental procedures in rodents[1][2].
